Triglycidylamine crosslinking of porcine aortic valve cusps or bovine pericardium results in improved biocompatibility, biomechanics, and calcification resistance: Chemical and biological mechanisms

American Journal of Pathology

Volumn 166, Issue 1, 2005, Pages 1-13

  Connolly, Jeanne M ^a   Alferiev, Ivan ^a   Clark Gruel, Jocelyn N ^e   Eidelman, Naomi ^b   Sacks, Michael ^c   Palmatory, Elizabeth ^a   Kronsteiner, Allyson ^a   DeFelice, Suzanne ^a   Xu, Jie ^a   Ohri, Rachit ^a   Narula, Navneet ^d   Vyavahare, Narendra ^a   Levy, Robert J ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY   (United States)

^c University of Pittsburgh   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINE; AMMONIA; BIOMATERIAL; EPICHLOROHYDRIN; EPOXIDE; GELATINASE A; GELATINASE B; GLUTARALDEHYDE; OSTEOPONTIN; POLYMER; SCLEROPROTEIN; TENASCIN; TRIGLYCIDYLAMINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; AORTA VALVE; ARTERY CALCIFICATION; ARTICLE; BIOCOMPATIBILITY; BIOMECHANICS; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS LINKING; ENZYME SUBSTRATE; HEART DISEASE; HEART VALVE PROSTHESIS; IMPLANT; IN VITRO STUDY; INTERMETHOD COMPARISON; LEYDIG CELL; NONHUMAN; PATHOPHYSIOLOGY; PERICARDIUM; PREMEDICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REACTION ANALYSIS; SHEEP; STATISTICAL SIGNIFICANCE; SWINE; SYNTHESIS; TEMPERATURE DEPENDENCE;

EID: 19944425114     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)62227-4     Document Type: Article

References (38)

1. Rahimtoola SH: Choice of prosthetic heart valve for adult patients. J Am Coll Cardiol 2003, 41:893-904
2. Levy RJ, Schoen FJ, Levy JT, Nelson AC, Howard SL, Oshry LJ: Biologic determinants of dystrophic calcification and osteocalcin deposition in glutaraldehyde-preserved porcine aortic valve leaflets implanted subcutaneously in rats. Am J Pathol 1983, 113:143-155
3. Schoen FJ, Levy RJ, Nelson AC, Bernhard WF, Nashef A, Hawley M: Onset and progression of experimental bioprosthetic heart valve calcification. Lab Invest 1985, 52:523-532
4. Kim KM, Herrera GA, Battarbee HD: Role of glutaraldehyde in calcification of porcine aortic valve fibroblasts. Am J Pathol 1999, 154:843-852
5. Dumont CE, Plissonnier D, Guettier C, Michel JB: Effects of glutaraldehyde on experimental arterial iso- and allografts in rats. J Surg Res 1993, 54:61-69
6. Xi T, Ma J, Tian W, Lei X, Long S, Xi B: Prevention of tissue calcification on bioprosthetic heart valve by using epoxy compounds: a study of calcification tests in vitro and in vivo. J Biomed Mater Res 1992, 26:1241-1251
7. Tu R, Shen SH, Lin D, Hata C, Thyagarajan K, Noishiki Y, Quijano RC: Fixation of bioprosthetic tissues with monofunctional and multifunctional polyepoxy compounds. J Biomed Mater Res 1994, 28:677-684
8. Hendriks M, Everaerts F, Verhoeven M: Alternative fixation of bioprostheses. J Long Term Eff Med Implants 2001, 11:163-183
9. Sung HW, Shen SH, Tu R, Lin D, Hata C, Noishiki Y, Tomizawa Y, Quijano RC: Comparison of the cross-linking characteristics of porcine heart valves fixed with glutaraldehyde or epoxy compounds. ASAIO J 1993, 39:M532-M536
10. Vyavahare N, Hirsch D, Lerner E, Baskin JZ, Schoen FJ, Bianco R, Kruth HS, Zand R, Levy RJ: Prevention of bioprosthetic heart valve calcification by ethanol preincubation. Efficacy and mechanisms. Circulation 1997, 95:479-488
11. Eidelman N, Simon JCG: Characterization of combinatorial polymer blend composition gradients by FTIR microspectroscopy. J Res Nat Inst 2004, J Res Natl Inst Stand Technol 2004, 109:219-231
12. Sacks MS, Chuong CJ: Orthotropic mechanical properties of chemically treated bovine pericardium. Ann Biomed Eng 1998, 26:892-902
13. Sun W, Sacks MS, Sellaro TL, Slaughter WS, Scott MJ: Biaxial mechanical response of bioprosthetic heart valve biomaterials to high in-plane shear. J Biomech Eng 2003, 125:372-380
14. Mirnajafi A, Raymer J, Scott MJ, Sacks MS: The effects of collagen fiber orientation on the flexural properties of pericardial heterograft biomaterials. Biomaterials 2004, 26:795-804
15. Gloeckner DC, Billiar KL, Sacks MS: Effects of mechanical fatigue on the bending properties of the porcine bioprosthetic heart valve. ASAIO J 1999, 45:59-63
16. Jian B, Jones PL, Li Q, Mohler III ER, Schoen FJ, Levy RJ: Matrix metalloproteinase-2 is associated with tenascin-C in calcific aortic stenosis. Am J Pathol 2001, 159:321-327
17. Jian B, Narula N, Li QY, Mohler III ER, Levy RJ: Progression of aortic valve stenosis: TGF-beta1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis. Ann Thorac Surg 2003, 75:456-465
18. Vyavahare N, Jones PL, Tallapragada S, Levy RJ: Inhibition of matrix metalloproteinase activity attenuates tenascin-C production and calcification of implanted purified elastin in rats. Am J Pathol 2000, 157:885-893
19. Wada T, McKee MD, Steitz S, Giachelli CM: Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin. Circ Res 1999, 84:166-178
20. Steitz SA, Speer MY, McKee MD, Liaw L, Almeida M, Yang H, Giachelli CM: Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification. Am J Pathol 2002, 161:2035-2046
21. Alferiev IS, Hinson JT, Ogle M, Breuer E, Levy RJ: High reactivity of alkyl sulfides towards epoxides under conditions of collagen fixation - a convenient approach to 2-amino-4-butyrolactones. Biomaterials 2001, 22:2501-2506
22. Levy RJ: Glutaraldehyde and the calcification mechanism of bioprosthetic heart valves. J Heart Valve Dis 1994, 3:101-104
23. Levy RJ, Schoen FJ, Langer R, Levy JT, Wolfrum J, Hawley MA, Lund SA, Carnes DL: Bioprosthetic heart valve calcification. The Chemistry and Biology of Mineralized Tissues. Edited by WT Butler. Birmingham, EBSCO Media, 1985, pp 375-380
24. Schoen FJ, Kujovich JL, Webb CL, Levy RJ: Chemically determined mineral content of explanted porcine aortic valve bioprostheses: correlation with radiographic assessment of calcification and clinical data. Circulation 1987, 76:1061-1066
25. Schoen FJ, Hirsch D, Bianco RW, Levy RJ: Onset and progression of calcification in porcine aortic bioprosthetic valves implanted as orthotopic mitral valve replacements in Juvenile sheep. J Thorac Cardiovasc Surg 1994, 108:880-887
26. Levy RJ, Schoen FJ, Flowers WB, Staelin ST: Initiation of mineralization in bioprosthetic heart valves: studies of alkaline phosphatase activity and its inhibition by AlCl3 or FeCl3 preincubations. J Biomed Mater Res 1991, 25:905-935
27. Bernacca GM, Dimitri WR, Fisher AC, Mackay TG, Wheatley DJ: Chemical modification of bovine pericardium and its effect on calcification in the rat subdermal model. Biomaterials 1992, 13:345-352
28. Vesely I, Noseworthy R, Pringle G: The hybrid xenograft/autograft bioprosthetic heart valve: in vivo evaluation of tissue extraction. Ann Thorac Surg 1995, 60:3359-3364
29. Grabenwoger M, Sider J, Fitzal F, Zelenka C, Windberger U, Grimm M, Moritz A, Bock P, Wolner E: Impact of glutaraldehyde on calcification of pericardial bioprosthetic heart valve material. Ann Thorac Surg 1996, 62:772-777
30. Simionescu DT, Lovekamp JJ, Vyavahare NR: Glycosaminoglycandegrading enzymes in porcine aortic heart valves: implications for bioprosthetic heart valve degeneration. J Heart Valve Dis 2003, 12:217-225
31. Cowan KN, Jones PL, Rabinovitch M: Regression of hypertrophied rat pulmonary arteries in organ culture is associated with suppression of proteolytic activity, inhibition of tenascin-C, and smooth muscle cell apoptosis. Circ Res 1999, 84:1223-1233
32. Cowan KN, Jones PL, Rabinovitch M: Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease. J Clin Invest 2000, 105:21-34
33. Beshensky AM, Wesson JA, Worcester EM, Sorokina EJ, Snyder CJ, Kleinman JG: Effects of urinary macromolecules on hydroxyapatite crystal formation. J Am Soc Nephrol 2001, 12:2108-2116
34. Dallas SL, Rosser JL, Mundy GR, Bonewald LF: Proteolysis of latent transforming growth factor-beta (TGF-beta)-binding protein-1 by osteoclasts. A cellular mechanism for release of TGF-beta from bone matrix. J Biol Chem 2002, 277:21352-21360
35. Satta J, Oìva J, Salo T, Eriksen H, Ohtonen P, Biancari F, Juvonen TS, Soini Y: Evidence for an altered balance between matrix metalloproteinase-9 and its inhibitors in calcific aortic stenosis. Ann Thorac Surg 2003, 76:681-688
36. Edep ME, Shirani J, Wolf P, Brown DL: Matrix metalloproteinase expression in nonrheumatic aortic stenosis. Cardiovasc Pathol 2000, 9:281-286
37. Simionescu A, Simionescu D, Deac R: Biochemical pathways of tissue degeneration in bioprosthetic cardiac valves. The role of matrix metalloproteinases. ASAIO J 1996, 42:M561-M567
38. Sacks MS, Schoen FJ: Collagen fiber disruption occurs independent of calcification in clinically explanted bioprosthetic heart valves. J Biomed Mater Res 2002, 62:359-371